Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women and WHO group II anovulatory infertile patients

Journal of Assisted Reproduction and Genetics

Volumn 15, Issue 9, 1998, Pages 552-559

  Balasch, Juan ^a,b   Fábregues, Francisco ^a   Peñarrubia, Joana ^a   Creus, Montserrat ^a   Vidal, Ricard ^a   Casamitjana, Roser ^a   Manau, Dolors ^a   Vanrell, Juan A ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

Induction of ovulation; Low dose follicle stimulating hormone (FSH) therapy; Recombinant FSH; WHO group II anovulation

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; INHIBIN A; RECOMBINANT FOLLITROPIN;

ADULT; ANOVULATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; HUMAN; INTRAUTERINE INSEMINATION; OVARY FOLLICLE DEVELOPMENT; OVULATION INDUCTION; PRIORITY JOURNAL;

EID: 0031793421     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1022586221077     Document Type: Article

References (41)

1. Kettel LM, Hummel WP: Ovulation induction in the estrogenized anovulatory patient. Semin Reprod Endocrinol 1996;14:309-315
2. WHO: WHO Scientific Group Report (B Lunenfeld, Chairman): Agents stimulating gonadal function in the human. WHO Tech Rep Ser 1973;514:1-28
3. Hill GA: The ovulatory factor and ovulation induction. In Gynecologic Endocrinology and Infertility, AC Wenta, CM Herbert III, GA Hill (eds). Baltimore, Williams and Wilkins, 1988, pp 147-160
4. Homburg R, Levy T, Ben-Rafael Z: A comparative prospective study of conventional regimen with chronic low-dose administration of follicle-stimulating hormone for anovulation associated with polycystic ovary syndrome. Fertil Steril 1995;63:729-733
5. Balen AH, Braat SS, West C, Patel A, Jacobs HS: Cumulative conception and life birth rates after the treatment of anovulatory infertility: Safety and efficacy of ovulation induction in 200 patients. Hum Reprod 1994;9:1563-1570
6. White DM, Poison DW, Kiddy D, Sagle P, Watson H, Gilling-Smith C, Hamilton-Fairley D, Franks S: Induction of ovulation with low-dose gonadotropins in polycystic ovary syndrome: An analysis of 109 pregnancies in 225 women. J Clin Endocrinol Metab 1996;81:3821-3824
7. Strowitzki T, Seehaus D, Korell M, Hepp H: Low-dose follicle stimulating hormone for ovulation induction in polycystic ovary syndrome. J Reprod Med 1994;39:499-503
8. Balasch J, Tur R, Peinado JA: The safety and effectiveness of stepwise and low-dose administration of follicle stimulating hormone in WHO group II anovulatory infertile women: Evidence from a large multicenter study in Spain. J Assist Reprod Genet 1996;13:551-556
9. Balasch J, Ballescá JL, Pimentel C, Creus M, Fábregues F, Vanrell JA: Late low-dose pure follicle stimulating hormone for ovarian stimulation in intra-uterine insemination cycles. Hum Reprod 1994;9:1863-1866
10. Bergh C, Howles CM, Borg K, Hamberger L, Josefsson B, Nilsson L, Wikland M: Recombinant human follicle stimulating hormone (r-hFSH; Gonal F) versus highly purified urinary FSH (Metrodin HP): Results of a randomized comparative study in women undergoing assisted reproductive techniques. Hum Reprod 1997;12:2133-2139
11. Adams J, Poison DW, Franks S: Prevalence of polycystic ovaries in women with anovulation or idiopathic hirsutism. BMJ 1986;293:355-359
12. Balasch J, Miró F, Burzaco I, Casamitjana R, Civico S, Ballescá JL, Puerto B, Vanrell JA: The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum Reprod 1995;10:1678-1683
13. Couzinet B, Lestrat N, Brailly S, Forest M, Schaison G: Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J Clin Endocrinol Metab 1988;66:552-556
14. Shoham Z, Balen A, Patel A, Jacobs HS: Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil Steril 1991;56:1048-1053
15. Balasch J, Creus M, Fábregues F, Casamitjana R, Ordi J, Vanrell JA: Midluteal immunoreactive α-inhibin serum concentrations as markers of luteal phase deficiency. Hum Reprod 1996;11:2591-2594
16. Groome NP, O'Brien M: Immunoassays for inhibin and its subunits. Further applications of the synthetic peptide approach. J Immunol Methods 1993;165:167-176
17. Groome NP, Illingwirth PJ, O'Brien M, Cooke I, Ganesan TS, Baird DT, McNeilly A: Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay. Clin Endocrinol 1994;40:717-723
18. Grunfeld L: Physiology of the menstrual cycle. Infertil Reprod Med Clin N Am 1991;2:673-697
19. Simoni M, Nieschlag E: FSH in therapy: Physiological basis, new preparations and clinical use. Reprod Med Rev 1995;4:163-177
20. Lunenfeld B, Lunenfeld E: Gonadotropic preparations-lessons learned. Fertil Steril 1997;67:812-814
21. Howles CM, Loumaye E, Giroud D, Luyet G: Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: A multicentre European phase III study. Hum Reprod 1994;9:424-430
22. Chappel S, Kelton C, Nugent N: Expression of human gonadotropins by recombinant DNA methods. In Proceedings of the 3rd World Congress on Gynecological Endocrinology, AR Genazzani, F Petraglia F (eds). Carnforth, UK, Parthenon, 1992, pp 179-184
23. Howles CM: Genetic engineering of human FSH (Gonal-F). Hum Reprod Update 1996;2:172-191.
24. Hull M, Corrigan E, Piazzi A, Loumaye E: Recombinant human luteinizing hormone: an effective new gonadotropin preparation. Lancet 1994;344:334-335
25. Hillier SG: Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum Reprod 1994;9:188-191
26. Out HJ, Mannaerts BMJL, Driessen SGAJ, Coelingh Bennink HJT: A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization. Hum Reprod 1995;10:2534-2540
27. Franks S: Polycystic ovary syndrome: A changing perspective. Clin Endocrinol 1989;51:87-120
28. Franks S: Polycystic ovary syndrome. N Engl J Med 1995;333:853-861
29. Fauser BCJM, Van Heusden AMV: Manipulation of human ovarian function: physiological concepts and clinical consequences. Endocr Rev 1997;18:71-106
30. Seibel MM, Kamreva MM, MacArdle C, Taymor ML: Treatment of polycystic ovary disease with chronic low-dose follicle stimulating hormone: Biochemical changes and ultrasound correlation. Int J Fertil 1984;29:39-43
31. Bergh C, Selleskog U, Hillensjö T: Recombinant human gonadotropins stimulate steroid and inhibin production in human granulosa cells. Eur J Endocrinol 1997;136:617-623
32. Lockwood GM, Muttukrishna S, Groome NP, Knight PG, Ledger WL: Circulating inhibins and activin A during GnRH-analogue down-regulation and ovarian hyperstimulation with recombinant FSH for in-vitro fertilization-embryo transfer. Clin Endocrinol 1996;45:741-748
33. Klein NA, Illingworth PJ, Groome NP, McNeilly AS, Battaglia DE, Soules MR: Decreased inhibin B secretion is associated with the monotropic FSH rise in older, ovulatory women: A study of serum and follicular fluid levels of dimeric inhibin A and B in spontaneous menstrual cycles. J Clin Endocrinol Metab 1996;81:2742-2745
34. Groome NP, Illingworth PJ, O'Brien M, Pai R, Rodger FE, Mather JP, McNeilly AS: Measurement of dimeric inhibin B throughout the human menstrual cycle. J Clin Endocrinol Metab 1996;81:1401-1405
35. Hillier SG, Wickings EJ, Illingworth PJ, Yong EL, Reichert LE Jr, Baird DT, McNeilly AS: Control of immunoactive inhibin production by human granulosa cells. Clin Endocrinol 1991;35:71-75
36. Gilling-Smith C, Willis DS, Franks S: Oestradiol feedback stimulation of androgen biosynthesis by human theca cells. Hum Reprod 1997;12:1621-1628
37. Millier SG, Yong EL, Illingworth PJ; Baird DT, Schwall RM, Mason AJ: Effect of recombinant inhibin on androgen synthesis in cultured human thecal cells. Mol Cell Endocrinol 1991;75:R1-R6
38. Hughes EG, Robertson DM, Handelsman DJ, Hayward S, Mealy DL, Kretser DM: Inhibin and estradiol responses to ovarian hyperstimulation: effects of age and predictive value for in vitro fertilization outcome. J Clin Endocrinol Metab 1990;70:358-364
39. Erickson GF, Yen SSC: The polycystic ovary syndrome. In The Ovary, EY Adashi, PCK Leung (eds). New York, Raven Press, 1993, pp.561-579
40. Mason HD, Mannaerts B, de Leeuw R, Willis DS, Franks S: Effects of recombinant human follicle stimulating hormone on cultured human granulosa cells: Comparison with urinary gonadotrophins and actions in preovulatory follicles. Hum Reprod 1993;8:1823-1827
41. Lambert A, Rodgers M, Mitchell R, Wood AM, Wardle C, Hilton B, Robertson WR: In-vitro biopotency and glycoform distribution of recombinant human follicle stimulating hormone (Org 32489), Metrodin and Metrodin-HP. Hum Reprod 1995;10:1928-1935